rosiglitazone has been researched along with Age-Related Osteoporosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Demuth, TP; Evdokimov, A; Hopkins, CR; Kontoyianni, M; Laufersweiler, MC; Mekel, M; O'neil, SV; Petrey, ME; Pokross, M; Richardson, E; Roesgen, JT; Sabatakos, G; Walter, R; Wang, Y | 1 |
| Andy, D; Erhardt, PW; Farris, JT; Heck, B; Heck, BE; Kim, DH; Kress, BJ; Mayo, JR; Sarver, JG; Trendel, JA | 1 |
| Chen, J; Chen, X; Peng, Y; Song, H; Xu, D; Zhao, S | 1 |
| Han, Y; Kim, MJ; Lee, KY | 1 |
| Debiais, F | 1 |
| Chambon, P; Fraser, DG; Géhin, M; Khosla, S; Mödder, UI; Monroe, DG; O'Malley, BW; Rosen, CJ; Spelsberg, TC | 1 |
| Gupta, S; Hrishikeshvan, HJ; Sehajpal, PK | 1 |
| Lecka-Czernik, B | 1 |
| Fantus, IG; Grynpas, MD; Renlund, R; Sardone, LD; Willett, TL | 1 |
| Ali, AA; Jilka, RL; Manolagas, SC; Parfitt, AM; Stewart, SA; Weinstein, RS | 1 |
| Hogue, WR; Lazarenko, OP; Lecka-Czernik, B; Rzonca, SO; Suva, LJ; Swain, FL | 1 |
| Quesada-Gómez, JM; Serrano-Alferez, I | 1 |
1 review(s) available for rosiglitazone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.
Topics: Animals; Bone Density; Cell Differentiation; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Osteoporosis; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |
11 other study(ies) available for rosiglitazone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis.
Topics: 3T3 Cells; Amides; Animals; Drug Design; Indoles; Mice; Osteoporosis; PPAR gamma | 2006 |
Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis.
Topics: Animals; Cell Differentiation; Disease Models, Animal; Drug Design; Female; Femur; Humans; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Osteogenesis; Osteoporosis; PPAR delta; Structure-Activity Relationship; Thiazoles; X-Ray Microtomography | 2021 |
Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs.
Topics: Adipogenesis; Animals; Drug Evaluation, Preclinical; Female; HEK293 Cells; Humans; Intercellular Signaling Peptides and Proteins; Mesenchymal Stem Cells; Mice, Inbred C57BL; Osteogenesis; Osteoporosis; PPAR gamma; Primary Cell Culture; Rosiglitazone; Thiazolidinediones | 2017 |
Berberine derivative, Q8, stimulates osteogenic differentiation.
Topics: Animals; Berberine; Cell Differentiation; Cell Line; Glycogen Synthase Kinase 3 beta; Mice; Myoblasts; Osteoblasts; Osteogenesis; Osteoporosis; Phosphorylation; PPAR gamma; Rosiglitazone | 2018 |
Thiazolidinediones: antidiabetic agents with effects on bone.
Topics: Aged; Animals; Bone and Bones; Bone Density; Bone Resorption; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Humans; Hypoglycemic Agents; Male; Mice; Osteoporosis; Pioglitazone; Randomized Controlled Trials as Topic; Rats; Rosiglitazone; Thiazolidinediones | 2009 |
Skeletal consequences of deletion of steroid receptor coactivator-2/transcription intermediary factor-2.
Topics: Adipocytes; Animals; Bone and Bones; Bone Marrow Cells; Cells, Cultured; Densitometry; Female; Gene Deletion; Gene Expression Regulation; Mice; Mice, Knockout; Models, Biological; Nuclear Receptor Coactivator 2; Osteoporosis; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed | 2009 |
Spirulina protects against rosiglitazone induced osteoporosis in insulin resistance rats.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Bone Density; Dexamethasone; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin Resistance; Male; Osteoporosis; Rats; Rats, Wistar; Rosiglitazone; Spirulina; Thiazolidinediones | 2010 |
Effect of rosiglitazone on bone quality in a rat model of insulin resistance and osteoporosis.
Topics: Alendronate; Animals; Biomechanical Phenomena; Bone and Bones; Bone Density Conservation Agents; Female; Hypoglycemic Agents; Insulin Resistance; Osteoporosis; Rats; Rosiglitazone; Thiazolidinediones | 2011 |
Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation.
Topics: Adipocytes; Aging; Animals; Bone and Bones; Cell Differentiation; Densitometry; Fatty Acids; Gene Expression Regulation; Hypoglycemic Agents; Ligands; Mesoderm; Mice; Osteoblasts; Osteoporosis; PPAR gamma; Rosiglitazone; Sp7 Transcription Factor; Stem Cells; Thiazolidinediones; Time Factors; Transcription Factors | 2005 |
Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.
Topics: Aging; Animals; Bone and Bones; Bone Density; Bone Resorption; Cell Differentiation; Compressive Strength; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed | 2007 |
Nonhypoglycemic effects of thiazolidinediones.
Topics: Adipocytes; Humans; Hypoglycemic Agents; Osteogenesis; Osteoporosis; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |